
Ecopia BioSciences Inc. — Investor Relations & Filings
Ecopia BioSciences Inc. is a biotechnology company specializing in the research and development of novel therapeutic solutions, primarily focusing on drug discovery. The company's core strategy involves identifying and developing anticancer agents derived from microorganisms, recognized as a historically prolific source of pharmaceutical compounds. Ecopia's pipeline includes lead drug candidate ECO-4601, an anticancer compound that has reached key patent milestones, and other candidates such as CAPTAT-414. The company leverages specialized R&D platforms for the development of organism and botanical-derived drugs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Other securityholders documents - English.pdf | 2007-04-11 | English | |
| Material change report - French.pdf | 2007-01-15 | English | |
| Material change report - English.pdf | 2007-01-05 | English | |
| Material change report - English.pdf | 2006-09-05 | English | |
| Material change report - English.pdf | 2006-07-14 | English | |
| Material change report - English.pdf | 2006-05-24 | English |
Browse filings by year
7 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
PROTEOME SCIENCES PLC
A Contract Research Organization focused on applied proteom…
|
PRM | GB | Professional, scientific and te… |
|
PROTEOMICS INTERNATIONAL LABORATORIES LTD
Develops proteomic diagnostics and provides analytical serv…
|
PIQ | AU | Professional, scientific and te… |
|
PROTHENA CORP PUBLIC LTD CO
Biotechnology company developing therapies for diseases of …
|
PRTA | US | Professional, scientific and te… |
|
PROVEXIS PLC
Develops and licenses functional ingredients for the food a…
|
PXS | GB | Professional, scientific and te… |
|
PR Technology Inc.
Specializes in low-frequency resonant Wireless Power Transm…
|
PRTI | CA | Professional, scientific and te… |
|
Psomagen, Inc.
A contract lab providing multiomics and data analysis solut…
|
950200 | US | Professional, scientific and te… |
|
Psych Capital Plc
Biopharmaceutical company developing psilocybin-based thera…
|
PSY | GB | Professional, scientific and te… |
|
PT Nanotech Indonesia Global Tbk
Pioneering nanotechnology, offering R&D, material engineeri…
|
NANO | ID | Professional, scientific and te… |
|
PULSE BIOSCIENCES, INC.
A bioelectric medicine company developing non-thermal nsPFA…
|
PLSE | US | Professional, scientific and te… |
|
PYC THERAPEUTICS LIMITED
Clinical-stage developer of RNA-based precision medicines f…
|
PYC | AU | Professional, scientific and te… |
Ecopia BioSciences Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45024/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45024 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45024 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45024 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45024}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ecopia BioSciences Inc. (id: 45024)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.